Journal of Biological Chemistry
Volume 286, Issue 17, 29 April 2011, Pages 15010-15021
Journal home page for Journal of Biological Chemistry

Signal Transduction
MAPK Scaffold IQGAP1 Binds the EGF Receptor and Modulates Its Activation*

https://doi.org/10.1074/jbc.M111.227694Get rights and content
Under a Creative Commons license
open access

Cellular responses produced by EGF are mediated through the receptor (EGFR) and by various enzymes and scaffolds. Recent studies document IQGAP1 as a scaffold for the MAPK cascade, binding directly to B-Raf, MEK, and ERK and regulating their activation in response to EGF. We previously showed that EGF is unable to activate B-Raf in cells lacking IQGAP1. However, the mechanism by which IQGAP1 links B-Raf to EGFR was unknown. Here we report that endogenous EGFR and IQGAP1 co-localize and co-immunoprecipitate in cells. EGF has no effect on the association, but Ca2+ attenuates binding. In vitro analysis demonstrated a direct association mediated through the IQ and kinase domains of IQGAP1 and EGFR, respectively. Calmodulin disrupts this interaction. Using a mass spectrometry-based assay, we show that EGF induces phosphorylation of IQGAP1 Ser1443, a residue known to be phosphorylated by PKC. This phosphorylation is eliminated by pharmacological inhibition of either EGFR or PKC and transfection with small interfering RNA directed against the PKCα isoform. In IQGAP1-null cells, EGF-stimulated tyrosine phosphorylation of EGFR is severely attenuated. Normal levels of autophosphorylation are restored by reconstituting wild type IQGAP1 and enhanced by an IQGAP1 S1443D mutant. Collectively, these data demonstrate a functional interaction between IQGAP1 and EGFR and suggest that IQGAP1 modulates EGFR activation.

MAP Kinases (MAPKs)
Mass Spectrometry (MS)
Protein Phosphorylation
Receptor Regulation
Receptor Tyrosine Kinase

Cited by (0)

*

This work was supported, in whole or in part, by a grant from the National Institutes of Health Grant RO1-CA93645 (to D. B. S.). This work was also supported by the Department of Defense Breast Cancer Research Program Grant BC087504 (FY08) (to C. D. W.).

1

Present address: Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02115.

2

Both authors contributed equally to this work.